Our partner is focused on developing therapies for rare and autoimmune diseases. Their approach targets key drivers of inflammation to address unmet medical needs, with the goal of improving patient outcomes and quality of life through innovative treatments.

This critical hire built and operationalized clinical biomarker strategies to support clinical development. They were a vital part of shaping the company's translational strategy and vision. This hire worked across research and development groups, collaborated with medical directors, clinical pharmacologists and nonclinical and discovery research scientists to ensure early definition of clinical development strategy, and agreement on biomarker needs. They were a key part of the team that provided strategic, technical and scientific leadership for development, implementation and data interpretation of an integrated translational research strategy.